References
1. Globocan 2012 - Home [Internet]. [cited 2015 Mar 28]. Available from: http://globocan.iarc.fr/Default.aspx.
2. Roxburgh CSD, McTaggart F, Balsitis M, Diament RH. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran. Colorectal Dis. 2013 Jan;15(1):34–41.
3. Mackay C, Ramsay G, Rafferty A, Loudon M. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre. J Eval Clin Pract. 2014 Feb;20(1):7–11.
4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–71.
5. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–7.
6. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–71.
7. Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane database Syst Rev. 2000 Jan;(2):CD001216.
8. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008 Jun;103(6):1541–9.
9. Estrategia en cáncer del Sistema Nacional de Salud. Madrid: Ministerio de Sani- dad y Consumo; 2006. 279 p. [Internet]. [cited 2015 Mar 28]. Available from: http://www.msssi.gob.es/eu/organizacion/sns/planCalidadSNS/pdf/excelencia/cancer-cardiopatia/CANCER/opsc_est1.pdf.pdf
10. Estrategia en Cáncer del Sistema Nacional de Salud Actualización aprobada por el Consejo Interterritorial del Sistema Nacional de Salud, el 22 de octubre de 2009 [Internet].[cited 2015 Mar 28]. Available from: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/pdf/ActualizacionEstrategiaCancer.pdf
11. Amri R, Bordeianou LG, Sylla P, Berger DL. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg. 2013 Aug;148(8):747–54.
12. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187–96.
13. Ostenfeld EB, Nørgaard M, Thomsen RW, Iversen LH, Jacobsen JB, Søgaard M. Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study. Clin Epidemiol. 2013 Jan;5(Suppl 1):65–74.
14. Libby G, Brewster DH, Steele RJC. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer. Br J Surg. 2014 Nov;101(12):1607–15.
15. Gunka I, Dostalik J, Martinek L, Gunkova P, Mazur M. Impact of blood transfusions on survival and recurrence in colorectal cancer surgery. Indian J Surg. 2013 Apr;75(2):94–101.
16. Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch K-W, Thasler WE. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum. 2015 Jan;58(1):74–82.
17. Kuzu MA, Terzioğlu H, Genç V, Erkek AB, Ozban M, Sonyürek P, et al. Preoperative nutritional risk assessment in predicting postoperative outcome in patients undergoing major surgery. World J Surg. 2006 Mar;30(3):378–90.
18. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg. 1999 Jan;134(1):36–42.
19. Longo WE, Virgo KS, Johnson FE, Oprian CA, Vernava AM, Wade TP, et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum. 2000 Jan;43(1):83–91.
20. Kudsk KA, Tolley EA, DeWitt RC, Janu PG, Blackwell AP, Yeary S, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003 Jan;27(1):1–9.
21. McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg. 2015 Feb 19;102(5):462–79.
22. Chima CS, Barco K, Dewitt MLA, Maeda M, Teran JC, Mullen KD. Relationship of Nutritional Status to Length of Stay, Hospital Costs, and Discharge Status of Patients Hospitalized in the Medicine Service. J Am Diet Assoc. 1997 Sep;97(9):975–8.
23. Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG. Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J. 2012 Jan;11:27.
24. Sun L-C, Chu K-S, Cheng S-C, Lu C-Y, Kuo C-H, Hsieh J-S, et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009 Jan;9:288.
25.Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006 Aug;40(7):592–5.
26. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J. 2010 Jan;9(1):69.
27. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal Cancer. Ann Surg. 2007 Dec;246(6):1047–51.
28. Alves A, Yves Panis, Danielle Trancar A. Factors Associated with Clinically Significant Anastomotic Leakage after Large Bowel Resection: Multivariate Analysis of 707 Patients. World J Surg. 2002 Jun 15;26(4):499–502.
29. Fazio VW, Tekkis PP, Remzi F, Lavery IC. Assessment of Operative Risk in Colorectal Cancer Surgery: The Cleveland Clinic Foundation Colorectal Cancer Model. Dis Colon Rectum. 2004 Dec;47(12):2015–24.
30. Lemmens VEPP, Janssen-Heijnen MLG, Verheij CDGW, Houterman S, Repelaer van Driel OJ, Coebergh JWW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005 May;92(5):615–23.